Medicare Enrolled
Dr. Jeremy Hubbard, M.D.
Urology Physician · Charlotte, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hubbard from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hubbard?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hubbard
Dr. Jeremy Hubbard is an urology physician in Charlotte, NC, with 19 years of NPI registration. Based on federal Medicare data, Dr. Hubbard performed 1,674 Medicare services across 1,221 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hubbard received a total of $10,113 from 60 pharmaceutical and/or device companies across 398 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hubbard is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 43% volume in NC
$10,113 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,674
Medicare services
Top 43% in NC for urology physician
1,221
Unique beneficiaries
$55
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~88 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
579 | $4 | $17 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
425 | $86 | $158 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
253 | $57 | $110 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
114 | $162 | $585 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
87 | $7 | $45 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
63 | $107 | $263 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
38 | $45 | $278 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
34 | $66 | $185 |
| 3D radiographic procedure A radiographic imaging technique that creates three-dimensional representations of internal structures. |
23 | $7 | $200 |
| Radiologist review of MRI guidance for needle placement A radiologist reviews the MRI images to guide the placement of a needle. This step ensures accurate positioning during a medical procedure. |
18 | $55 | $875 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
14 | $159 | $626 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
14 | $82 | $295 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
12 | $330 | $1,927 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.7% high complexity
7.9% medium
91.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,113
Total received (2018-2024)
Avg $1,445/year across 7 years
Top 18% in NC for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
398
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,066 (89.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,046 (10.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,974
2023
$1,867
2022
$1,506
2021
$1,450
2020
$702
2019
$921
2018
$1,693
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Dendreon Pharmaceuticals LLC
$340
Sumitomo Pharma America, Inc.
$311
UROGEN PHARMA, INC.
$166
Laborie Medical Technologies Corp.
$140
Axonics, Inc.
$134
Myriad Genetic Laboratories, Inc.
$121
Olympus America Inc.
$102
Boston Scientific Corporation
$70
Tolmar, Inc.
$70
Ferring Pharmaceuticals Inc.
$67
Endo USA, Inc.
$65
PFIZER INC.
$62
Antares Pharma, Inc.
$57
ABBVIE INC.
$51
Mission Pharmacal Company
$50
AngioDynamics, Inc.
$42
Endo Pharmaceuticals Inc.
$35
Merck Sharp & Dohme LLC
$27
ACCORD HEALTHCARE, INC.
$24
PROCEPT BioRobotics Corporation
$21
PROGENICS PHARMACEUTICALS, INC.
$20
Top 3 companies account for 41.4% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,062
Coloplast Corp
$905
Sumitomo Pharma America, Inc.
$779
Endo Pharmaceuticals Inc.
$644
Boston Scientific Corporation
$492
Dendreon Pharmaceuticals LLC
$466
Antares Pharma, Inc.
$373
Axonics, Inc.
$365
Laborie Medical Technologies Corp.
$304
TOLMAR Pharmaceuticals, Inc.
$285
Myovant Sciences Inc.
$244
ABBVIE INC.
$221
NeoTract Inc.
$214
UROGEN PHARMA, INC.
$213
Tolmar, Inc.
$178
PFIZER INC.
$176
COLOPLAST CORP
$172
Ethicon US, LLC
$172
Blue Earth Diagnostics Limited
$152
PROCEPT BioRobotics Corporation
$149
Medtronic, Inc.
$141
Olympus America Inc.
$137
Clarus Therapeutics Inc.
$136
UROVANT SCIENCES INC
$135
Myriad Genetic Laboratories, Inc.
$121
AbbVie Inc.
$120
Merck Sharp & Dohme Corporation
$114
Mission Pharmacal Company
$114
Merck Sharp & Dohme LLC
$114
Avadel Specialty Pharmaceuticals, LLC
$110
UroGen Pharma, Inc.
$108
Allergan Inc.
$105
Janssen Biotech, Inc.
$104
ACCORD HEALTHCARE, INC.
$95
ConvaTec Inc.
$73
MEDIVATION FIELD SOLUTIONS LLC
$72
Boehringer Ingelheim Pharmaceuticals, Inc.
$71
Ferring Pharmaceuticals Inc.
$67
Endo USA, Inc.
$65
NxThera, Inc.
$51
Agiliti Health, Inc.
$48
Amgen Inc.
$45
AngioDynamics, Inc.
$42
BOSTON SCIENTIFIC CORPORATION
$38
AbbVie, Inc.
$36
Acerus Pharmaceuticals Corporation
$36
Sun Pharmaceutical Industries Inc.
$35
PROGENICS PHARMACEUTICALS, INC.
$20
Progenics Pharmaceuticals, Inc.
$20
180 Medical, Inc.
$19
Smith+Nephew, Inc.
$18
GENZYME CORPORATION
$18
AMAG Pharmaceuticals, Inc.
$17
Allergan, Inc.
$17
Hollister Incorporated
$16
Bayer HealthCare Pharmaceuticals Inc.
$15
Egalet US Inc
$14
Zyla Life Sciences
$14
Kowa Pharmaceuticals America, Inc.
$13
SRS Medical Systems, Inc.
$12
Top 3 companies account for 27.2% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · ADVANCE · AMS · AMS 700 · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · AdVance XP · Altis · Androgel · Axonics · Axonics r-SNM System · Axumin · BOTOX · BOTOX THERAPEUTIC · Bulkamid · CAMCEVI · CONTINENCE CARE · DUPIXENT · ECHELON ENDOPATH · ECHELON FLEX Stapler · EDEX · ELIGARD · ERLEADA · Echelon Flex · Erleada · GEMTESA · GENERAL THERAPIES · GENTLECATH · GREENLIGHT · INTERSTIM · INTRAROSA · Infyna Chic · JARDIANCE · JATENZO · JELMYTO · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LithoVue · Lupron Depot · MYRBETRIQ · Myrbetriq · NANOKNIFE · NOCDURNA · Natesto · Noctiva · ORGOVYX · OTREXUP · Optilume BPH Drug Coated Balloon Catheter · Otrexup · PROLARIS · PROVENGE · PYLARIFY · Porges Coloplast · Prolia · REZUM · Rezum · Rezum Generator · SPEEDICATH · SPRIX · STRATAFIX · STRAVIX · SUTENT · Seglentis · SpaceOAR VUE System - 10mL · SpeediCath · Surgicel Powder · TITAN · TOVIAZ · TRIA · Titan · URIBEL · URIBEL TABS · Uribel · UroCuff · UroLift · VESICARE · VISTASEAL · XALKORI · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · YONSA · YONSA (abiraterone acetate) · iTIND System · injeTAK Adjustable Tip Needle 70cm
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
72
Per 100K population
6.4
County median income
$83,765
Nearest hospital
ATRIUM HEALTH UNIVERSITY CITY
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hubbard is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 18% of NC peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hubbard experienced with manual urinalysis with microscopic examination?
Based on Medicare claims data, Dr. Hubbard performed 579 manual urinalysis with microscopic examination services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hubbard receive payments from pharmaceutical companies?
Yes. Dr. Hubbard received a total of $10,113 from 60 companies across 398 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hubbard's costs compare to other urology physicians in Charlotte?
Dr. Hubbard's average Medicare payment per service is $55. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hubbard) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Charlotte
Browse urology physicians in Charlotte ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NC
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NC
Which NC urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Coloplast Corp Payments to Doctors
See all physicians who received payments from Coloplast Corp.
By company
Sumitomo Pharma America, Inc. Payments to Doctors
See all physicians who received payments from Sumitomo Pharma America, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology